Our History Header.jpg
Our History page thumbnail.jpg

Our History

BBI Solutions history timeline

BBI was founded in 1986, when John Chandler at Cardiff University developed and manufactured our now world-renowned gold nanoparticles for the first time and supplied them to the electron microscopy industry.

Since then, the company has grown its portfolio of products to include gold reagents, antibodies, antigens, enzymes, serum and plasma, cell culture reagents as well as offering antibody development services, lateral flow assay development and manufacture.

See how we have grown


The BBI Group was established in 1986 with only 10 staff…
And had a turnover of less than £1 Million.


BBI achieved an MBO.


BBI achieved an IPO.


Growth continues through the product and service, acquisitions and new entities.


The BBI Group was sold to Alere for £85m. Alere are a global POC leader.


We rebranded to bring our complete offering together as BBI Solutions.


The BBI Group became an independent company following an the acquisition by Exponent Private Equity.


BBI Solutions acquired Novarum DX Ltd.


Invested £14m in the new BBI Group Global Headquarters.


April 2020, BBI Group joins the UK Rapid Test Consortium to rapidly develop and rollout the Coronavirus tests.
June 2020, BBI Group acquires DIARECT AG, establishing BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets


Aquisition of BBI group by Novo Holdings


January 2022 aquisition of Biotez GmbH and Steffens Biotechnische Analysen GmbH




Receive regular industry insights and the latest BBI Solutions' news & product launch information by signing up to our Newsletter